Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(CTLA 4). Showing records 1 – 30 of 36 total matches.

[1] [2]

Search Limiters

Last 2 Years | English Only

▼ Search Limiters


University of Rochester

1. Modjeski, Kristina Louise. A Role for Glutamate Receptor Interacting Protein 1 in Platelets and T Cells.

Degree: PhD, 2015, University of Rochester

 PDZ molecular scaffolding proteins have been most studied in neurons, but are present in other cells. PDZ proteins typically bind membrane proteins to regulate receptor… (more)

Subjects/Keywords: Platelets; Adhesion; Transplantation; TCells; CTLA-4

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Modjeski, K. L. (2015). A Role for Glutamate Receptor Interacting Protein 1 in Platelets and T Cells. (Doctoral Dissertation). University of Rochester. Retrieved from http://hdl.handle.net/1802/30116

Chicago Manual of Style (16th Edition):

Modjeski, Kristina Louise. “A Role for Glutamate Receptor Interacting Protein 1 in Platelets and T Cells.” 2015. Doctoral Dissertation, University of Rochester. Accessed January 17, 2021. http://hdl.handle.net/1802/30116.

MLA Handbook (7th Edition):

Modjeski, Kristina Louise. “A Role for Glutamate Receptor Interacting Protein 1 in Platelets and T Cells.” 2015. Web. 17 Jan 2021.

Vancouver:

Modjeski KL. A Role for Glutamate Receptor Interacting Protein 1 in Platelets and T Cells. [Internet] [Doctoral dissertation]. University of Rochester; 2015. [cited 2021 Jan 17]. Available from: http://hdl.handle.net/1802/30116.

Council of Science Editors:

Modjeski KL. A Role for Glutamate Receptor Interacting Protein 1 in Platelets and T Cells. [Doctoral Dissertation]. University of Rochester; 2015. Available from: http://hdl.handle.net/1802/30116


Linnaeus University

2. Georgsson, Jonathan. Är CTLA-4-inhibitorn ipilimumab bättre som monoterapi eller i kombination med andra läkemedel hos patienter med metastaserat malignt melanom?.

Degree: Chemistry and Biomedical Sciences, 2016, Linnaeus University

  Malignant melanoma is a growing problem with more and more people in Sweden and the world suffering from this cancer. Malignant melanoma is a… (more)

Subjects/Keywords: Ipilimumab; CTLA-4; Pharmaceutical Sciences; Farmaceutiska vetenskaper

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Georgsson, J. (2016). Är CTLA-4-inhibitorn ipilimumab bättre som monoterapi eller i kombination med andra läkemedel hos patienter med metastaserat malignt melanom?. (Thesis). Linnaeus University. Retrieved from http://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-52662

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Georgsson, Jonathan. “Är CTLA-4-inhibitorn ipilimumab bättre som monoterapi eller i kombination med andra läkemedel hos patienter med metastaserat malignt melanom?.” 2016. Thesis, Linnaeus University. Accessed January 17, 2021. http://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-52662.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Georgsson, Jonathan. “Är CTLA-4-inhibitorn ipilimumab bättre som monoterapi eller i kombination med andra läkemedel hos patienter med metastaserat malignt melanom?.” 2016. Web. 17 Jan 2021.

Vancouver:

Georgsson J. Är CTLA-4-inhibitorn ipilimumab bättre som monoterapi eller i kombination med andra läkemedel hos patienter med metastaserat malignt melanom?. [Internet] [Thesis]. Linnaeus University; 2016. [cited 2021 Jan 17]. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-52662.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Georgsson J. Är CTLA-4-inhibitorn ipilimumab bättre som monoterapi eller i kombination med andra läkemedel hos patienter med metastaserat malignt melanom?. [Thesis]. Linnaeus University; 2016. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-52662

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Kansas

3. Newton, Amy Nicole. Novel roles for CD23, CTLA-4 and lipoproteins in human T cell function and differentiation.

Degree: PhD, Molecular Biosciences, 2014, University of Kansas

 The differentiation of multipotent naïve T cells is influenced by the microenvironment. Cytokines, costimulatory proteins and other biological factors can tune this differentiation process, influencing… (more)

Subjects/Keywords: Immunology; CTLA-4; differentiation; T cell

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Newton, A. N. (2014). Novel roles for CD23, CTLA-4 and lipoproteins in human T cell function and differentiation. (Doctoral Dissertation). University of Kansas. Retrieved from http://hdl.handle.net/1808/19603

Chicago Manual of Style (16th Edition):

Newton, Amy Nicole. “Novel roles for CD23, CTLA-4 and lipoproteins in human T cell function and differentiation.” 2014. Doctoral Dissertation, University of Kansas. Accessed January 17, 2021. http://hdl.handle.net/1808/19603.

MLA Handbook (7th Edition):

Newton, Amy Nicole. “Novel roles for CD23, CTLA-4 and lipoproteins in human T cell function and differentiation.” 2014. Web. 17 Jan 2021.

Vancouver:

Newton AN. Novel roles for CD23, CTLA-4 and lipoproteins in human T cell function and differentiation. [Internet] [Doctoral dissertation]. University of Kansas; 2014. [cited 2021 Jan 17]. Available from: http://hdl.handle.net/1808/19603.

Council of Science Editors:

Newton AN. Novel roles for CD23, CTLA-4 and lipoproteins in human T cell function and differentiation. [Doctoral Dissertation]. University of Kansas; 2014. Available from: http://hdl.handle.net/1808/19603

4. Coutzac, Clélia. Immunomodulation par les anticorps monoclonaux thérapeutiques bloquant CTLA-4 : rôle de la flore intestinale et de ses métabolites : Immunomodulation with CTLA-4 blockade monoclonal antibodies : role of gut microbiota and its metabolites.

Degree: Docteur es, Sciences de la vie et de la santé, 2017, Université Paris-Saclay (ComUE)

Au cours des dernières années, l’immunothérapie a révolutionné le paysage en oncologie. L’anti-CTLA-4 a montré son efficacité sur la survie globale des patients atteints de… (more)

Subjects/Keywords: Colite; Ctla-4; Immunothérapie; Cancer; Microbiote intestinal; Butyrate; Colitis; Ctla-4; Immunotherapy; Cancer; Gut Microbiota; Butyrate

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Coutzac, C. (2017). Immunomodulation par les anticorps monoclonaux thérapeutiques bloquant CTLA-4 : rôle de la flore intestinale et de ses métabolites : Immunomodulation with CTLA-4 blockade monoclonal antibodies : role of gut microbiota and its metabolites. (Doctoral Dissertation). Université Paris-Saclay (ComUE). Retrieved from http://www.theses.fr/2017SACLS396

Chicago Manual of Style (16th Edition):

Coutzac, Clélia. “Immunomodulation par les anticorps monoclonaux thérapeutiques bloquant CTLA-4 : rôle de la flore intestinale et de ses métabolites : Immunomodulation with CTLA-4 blockade monoclonal antibodies : role of gut microbiota and its metabolites.” 2017. Doctoral Dissertation, Université Paris-Saclay (ComUE). Accessed January 17, 2021. http://www.theses.fr/2017SACLS396.

MLA Handbook (7th Edition):

Coutzac, Clélia. “Immunomodulation par les anticorps monoclonaux thérapeutiques bloquant CTLA-4 : rôle de la flore intestinale et de ses métabolites : Immunomodulation with CTLA-4 blockade monoclonal antibodies : role of gut microbiota and its metabolites.” 2017. Web. 17 Jan 2021.

Vancouver:

Coutzac C. Immunomodulation par les anticorps monoclonaux thérapeutiques bloquant CTLA-4 : rôle de la flore intestinale et de ses métabolites : Immunomodulation with CTLA-4 blockade monoclonal antibodies : role of gut microbiota and its metabolites. [Internet] [Doctoral dissertation]. Université Paris-Saclay (ComUE); 2017. [cited 2021 Jan 17]. Available from: http://www.theses.fr/2017SACLS396.

Council of Science Editors:

Coutzac C. Immunomodulation par les anticorps monoclonaux thérapeutiques bloquant CTLA-4 : rôle de la flore intestinale et de ses métabolites : Immunomodulation with CTLA-4 blockade monoclonal antibodies : role of gut microbiota and its metabolites. [Doctoral Dissertation]. Université Paris-Saclay (ComUE); 2017. Available from: http://www.theses.fr/2017SACLS396

5. 安井, 順一. Minor contribution of cytotoxic T lymphocyte antigen 4 and programmed cell death ligand 1 in immune tolerance against mouse thyrotropin receptor in mice : マウスTSH受容体に対する免疫寛容におけるCTLA-4とPD-L1の寄与は僅かである。.

Degree: 博士(医学), 2015, Nagasaki University / 長崎大学

 We have previously shown that wild type (wt) mice exhibit susceptibility to immunization with human (h) thyrotropin receptor (TSHR), but resistance to mouse (m) TSHR,… (more)

Subjects/Keywords: thyrotropin receptor; CTLA-4; PD-L 1; Grave's disease

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

安井, . (2015). Minor contribution of cytotoxic T lymphocyte antigen 4 and programmed cell death ligand 1 in immune tolerance against mouse thyrotropin receptor in mice : マウスTSH受容体に対する免疫寛容におけるCTLA-4とPD-L1の寄与は僅かである。. (Thesis). Nagasaki University / 長崎大学. Retrieved from http://hdl.handle.net/10069/36009

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

安井, 順一. “Minor contribution of cytotoxic T lymphocyte antigen 4 and programmed cell death ligand 1 in immune tolerance against mouse thyrotropin receptor in mice : マウスTSH受容体に対する免疫寛容におけるCTLA-4とPD-L1の寄与は僅かである。.” 2015. Thesis, Nagasaki University / 長崎大学. Accessed January 17, 2021. http://hdl.handle.net/10069/36009.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

安井, 順一. “Minor contribution of cytotoxic T lymphocyte antigen 4 and programmed cell death ligand 1 in immune tolerance against mouse thyrotropin receptor in mice : マウスTSH受容体に対する免疫寛容におけるCTLA-4とPD-L1の寄与は僅かである。.” 2015. Web. 17 Jan 2021.

Vancouver:

安井 . Minor contribution of cytotoxic T lymphocyte antigen 4 and programmed cell death ligand 1 in immune tolerance against mouse thyrotropin receptor in mice : マウスTSH受容体に対する免疫寛容におけるCTLA-4とPD-L1の寄与は僅かである。. [Internet] [Thesis]. Nagasaki University / 長崎大学; 2015. [cited 2021 Jan 17]. Available from: http://hdl.handle.net/10069/36009.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

安井 . Minor contribution of cytotoxic T lymphocyte antigen 4 and programmed cell death ligand 1 in immune tolerance against mouse thyrotropin receptor in mice : マウスTSH受容体に対する免疫寛容におけるCTLA-4とPD-L1の寄与は僅かである。. [Thesis]. Nagasaki University / 長崎大学; 2015. Available from: http://hdl.handle.net/10069/36009

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Universidade de Brasília

6. Viviane Furlan Lozano. Análise de polimorfismo no gene CTLA-4 em pacientes com paracoccidioidomicose.

Degree: 2008, Universidade de Brasília

A proteína CTLA-4 é expressa principalmente em células T ativadas, possuindo um papel fundamental na resposta imune, exercendo efeito regulador na ativação de célula T… (more)

Subjects/Keywords: paracoccidioidomicose; ancestralidade; GENETICA; SNP -318; SNP +49; CTLA-4; polimorfismos

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lozano, V. F. (2008). Análise de polimorfismo no gene CTLA-4 em pacientes com paracoccidioidomicose. (Thesis). Universidade de Brasília. Retrieved from http://bdtd.bce.unb.br/tedesimplificado/tde_busca/arquivo.php?codArquivo=3303

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Lozano, Viviane Furlan. “Análise de polimorfismo no gene CTLA-4 em pacientes com paracoccidioidomicose.” 2008. Thesis, Universidade de Brasília. Accessed January 17, 2021. http://bdtd.bce.unb.br/tedesimplificado/tde_busca/arquivo.php?codArquivo=3303.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Lozano, Viviane Furlan. “Análise de polimorfismo no gene CTLA-4 em pacientes com paracoccidioidomicose.” 2008. Web. 17 Jan 2021.

Vancouver:

Lozano VF. Análise de polimorfismo no gene CTLA-4 em pacientes com paracoccidioidomicose. [Internet] [Thesis]. Universidade de Brasília; 2008. [cited 2021 Jan 17]. Available from: http://bdtd.bce.unb.br/tedesimplificado/tde_busca/arquivo.php?codArquivo=3303.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Lozano VF. Análise de polimorfismo no gene CTLA-4 em pacientes com paracoccidioidomicose. [Thesis]. Universidade de Brasília; 2008. Available from: http://bdtd.bce.unb.br/tedesimplificado/tde_busca/arquivo.php?codArquivo=3303

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Sydney

7. Gide, Tuba Nur. Biomarkers of response and resistance to anti-PD1 immunotherapy in melanoma.

Degree: 2019, University of Sydney

 Inhibitors targeting the CTLA-4 and PD-1 receptors have greatly improved the survival and outcomes of patients with advanced stage melanoma. There are currently numerous Phase… (more)

Subjects/Keywords: melanoma; immunotherapy; anti-PD-1; anti-CTLA-4

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gide, T. N. (2019). Biomarkers of response and resistance to anti-PD1 immunotherapy in melanoma. (Thesis). University of Sydney. Retrieved from http://hdl.handle.net/2123/21200

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Gide, Tuba Nur. “Biomarkers of response and resistance to anti-PD1 immunotherapy in melanoma. ” 2019. Thesis, University of Sydney. Accessed January 17, 2021. http://hdl.handle.net/2123/21200.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Gide, Tuba Nur. “Biomarkers of response and resistance to anti-PD1 immunotherapy in melanoma. ” 2019. Web. 17 Jan 2021.

Vancouver:

Gide TN. Biomarkers of response and resistance to anti-PD1 immunotherapy in melanoma. [Internet] [Thesis]. University of Sydney; 2019. [cited 2021 Jan 17]. Available from: http://hdl.handle.net/2123/21200.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Gide TN. Biomarkers of response and resistance to anti-PD1 immunotherapy in melanoma. [Thesis]. University of Sydney; 2019. Available from: http://hdl.handle.net/2123/21200

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

8. Fields, Maria. Homeostasis and function of Regulatory T Cells during Human Immunodeficiency Virus infection.

Degree: PhD, Medicine: Immunology, 2014, University of Cincinnati

 HIV infection remains an important public health problem worldwide, at the end of 2011 UNAIDS estimated that there were 34.0 million people living with HIV… (more)

Subjects/Keywords: Immunology; Treg; HIV; cAMP; CTLA-4; HDL; Actin

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fields, M. (2014). Homeostasis and function of Regulatory T Cells during Human Immunodeficiency Virus infection. (Doctoral Dissertation). University of Cincinnati. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=ucin1408709850

Chicago Manual of Style (16th Edition):

Fields, Maria. “Homeostasis and function of Regulatory T Cells during Human Immunodeficiency Virus infection.” 2014. Doctoral Dissertation, University of Cincinnati. Accessed January 17, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1408709850.

MLA Handbook (7th Edition):

Fields, Maria. “Homeostasis and function of Regulatory T Cells during Human Immunodeficiency Virus infection.” 2014. Web. 17 Jan 2021.

Vancouver:

Fields M. Homeostasis and function of Regulatory T Cells during Human Immunodeficiency Virus infection. [Internet] [Doctoral dissertation]. University of Cincinnati; 2014. [cited 2021 Jan 17]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1408709850.

Council of Science Editors:

Fields M. Homeostasis and function of Regulatory T Cells during Human Immunodeficiency Virus infection. [Doctoral Dissertation]. University of Cincinnati; 2014. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1408709850

9. Jacquelot, Nicolas. Impact du système immunitaire dans le mélanome métastatique : étude de son rôle pronostique et prédictif. : The Immune System in Metastatic Melanoma : Prognostic and Predictive Roles.

Degree: Docteur es, Sciences de la vie et de la santé, 2016, Université Paris-Saclay (ComUE)

Le mélanome métastatique reste un enjeu majeur de santé publique. Les avancées fulgurantes de ces dernières années ont permis d’améliorer la prise en charge thérapeutique,… (more)

Subjects/Keywords: Mélanome métastatique; Système immunitaire; Chimiokines; Anti-PD-1; Anti-CTLA-4; Metastatic melanoma; Immune system; Chemokines; Anti-PD-1; Anti-CTLA-4

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jacquelot, N. (2016). Impact du système immunitaire dans le mélanome métastatique : étude de son rôle pronostique et prédictif. : The Immune System in Metastatic Melanoma : Prognostic and Predictive Roles. (Doctoral Dissertation). Université Paris-Saclay (ComUE). Retrieved from http://www.theses.fr/2016SACLS142

Chicago Manual of Style (16th Edition):

Jacquelot, Nicolas. “Impact du système immunitaire dans le mélanome métastatique : étude de son rôle pronostique et prédictif. : The Immune System in Metastatic Melanoma : Prognostic and Predictive Roles.” 2016. Doctoral Dissertation, Université Paris-Saclay (ComUE). Accessed January 17, 2021. http://www.theses.fr/2016SACLS142.

MLA Handbook (7th Edition):

Jacquelot, Nicolas. “Impact du système immunitaire dans le mélanome métastatique : étude de son rôle pronostique et prédictif. : The Immune System in Metastatic Melanoma : Prognostic and Predictive Roles.” 2016. Web. 17 Jan 2021.

Vancouver:

Jacquelot N. Impact du système immunitaire dans le mélanome métastatique : étude de son rôle pronostique et prédictif. : The Immune System in Metastatic Melanoma : Prognostic and Predictive Roles. [Internet] [Doctoral dissertation]. Université Paris-Saclay (ComUE); 2016. [cited 2021 Jan 17]. Available from: http://www.theses.fr/2016SACLS142.

Council of Science Editors:

Jacquelot N. Impact du système immunitaire dans le mélanome métastatique : étude de son rôle pronostique et prédictif. : The Immune System in Metastatic Melanoma : Prognostic and Predictive Roles. [Doctoral Dissertation]. Université Paris-Saclay (ComUE); 2016. Available from: http://www.theses.fr/2016SACLS142


NSYSU

10. Chen, I-ya. Costimulatory molecules as genetic markers for relapse of Gravesâ disease.

Degree: Master, Biological Sciences, 2009, NSYSU

 Gravesâ disease (GD), an organ specific autoimmune disease, requires two signals to activate the T cells. In addition to the specific binding of T cell… (more)

Subjects/Keywords: CD40; PDCD-1; ICOS; CTLA-4; CD28; costimulatory factor; Graves' disease; haplotype; single nucleotide polymorphism

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chen, I. (2009). Costimulatory molecules as genetic markers for relapse of Gravesâ disease. (Thesis). NSYSU. Retrieved from http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0323109-115415

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Chen, I-ya. “Costimulatory molecules as genetic markers for relapse of Gravesâ disease.” 2009. Thesis, NSYSU. Accessed January 17, 2021. http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0323109-115415.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Chen, I-ya. “Costimulatory molecules as genetic markers for relapse of Gravesâ disease.” 2009. Web. 17 Jan 2021.

Vancouver:

Chen I. Costimulatory molecules as genetic markers for relapse of Gravesâ disease. [Internet] [Thesis]. NSYSU; 2009. [cited 2021 Jan 17]. Available from: http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0323109-115415.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Chen I. Costimulatory molecules as genetic markers for relapse of Gravesâ disease. [Thesis]. NSYSU; 2009. Available from: http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0323109-115415

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Washington University in St. Louis

11. Elliott, Jabari Issa. Structural Mechanism of Poxvirus Sabotage of T-cell Costimulation.

Degree: PhD, Biology & Biomedical Sciences (Biochemistry), 2020, Washington University in St. Louis

 Poxviruses are characterized by large double stranded DNA genomes that encode numerous proteins tailored for host immune response evasion. Our lab has been investigating a… (more)

Subjects/Keywords: CD28, Cowpox Virus, Cryo-EM, CTLA-4, Immune Evasion, T cell; Biochemistry; Biophysics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Elliott, J. I. (2020). Structural Mechanism of Poxvirus Sabotage of T-cell Costimulation. (Doctoral Dissertation). Washington University in St. Louis. Retrieved from https://openscholarship.wustl.edu/art_sci_etds/2182

Chicago Manual of Style (16th Edition):

Elliott, Jabari Issa. “Structural Mechanism of Poxvirus Sabotage of T-cell Costimulation.” 2020. Doctoral Dissertation, Washington University in St. Louis. Accessed January 17, 2021. https://openscholarship.wustl.edu/art_sci_etds/2182.

MLA Handbook (7th Edition):

Elliott, Jabari Issa. “Structural Mechanism of Poxvirus Sabotage of T-cell Costimulation.” 2020. Web. 17 Jan 2021.

Vancouver:

Elliott JI. Structural Mechanism of Poxvirus Sabotage of T-cell Costimulation. [Internet] [Doctoral dissertation]. Washington University in St. Louis; 2020. [cited 2021 Jan 17]. Available from: https://openscholarship.wustl.edu/art_sci_etds/2182.

Council of Science Editors:

Elliott JI. Structural Mechanism of Poxvirus Sabotage of T-cell Costimulation. [Doctoral Dissertation]. Washington University in St. Louis; 2020. Available from: https://openscholarship.wustl.edu/art_sci_etds/2182


University of Minnesota

12. Zumwalde, Nicholas Alan. The role of ICAM-1 mediated T cell:T cell interactions on CD8+ T cell effector function and differentiation.

Degree: PhD, Microbiology, Immunology and Cancer Biology, 2013, University of Minnesota

 CD8+ T cells are vital components to the immune system and serve as crucial effectors in the elimination of infected cells and pathogens. During the… (more)

Subjects/Keywords: CD8+ T cells; CTLA-4; Effector function; ICAM-1; Inhibition; T cell clusters

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zumwalde, N. A. (2013). The role of ICAM-1 mediated T cell:T cell interactions on CD8+ T cell effector function and differentiation. (Doctoral Dissertation). University of Minnesota. Retrieved from http://purl.umn.edu/151553

Chicago Manual of Style (16th Edition):

Zumwalde, Nicholas Alan. “The role of ICAM-1 mediated T cell:T cell interactions on CD8+ T cell effector function and differentiation.” 2013. Doctoral Dissertation, University of Minnesota. Accessed January 17, 2021. http://purl.umn.edu/151553.

MLA Handbook (7th Edition):

Zumwalde, Nicholas Alan. “The role of ICAM-1 mediated T cell:T cell interactions on CD8+ T cell effector function and differentiation.” 2013. Web. 17 Jan 2021.

Vancouver:

Zumwalde NA. The role of ICAM-1 mediated T cell:T cell interactions on CD8+ T cell effector function and differentiation. [Internet] [Doctoral dissertation]. University of Minnesota; 2013. [cited 2021 Jan 17]. Available from: http://purl.umn.edu/151553.

Council of Science Editors:

Zumwalde NA. The role of ICAM-1 mediated T cell:T cell interactions on CD8+ T cell effector function and differentiation. [Doctoral Dissertation]. University of Minnesota; 2013. Available from: http://purl.umn.edu/151553


University of Maryland

13. Cano-Mejia, Juliana. Biodegradable Prussian blue nanoparticles for photothermal immunotherapy of advanced cancers.

Degree: Bioengineering, 2015, University of Maryland

 Multifunctional nanoparticles represent a class of materials with diverse therapy and imaging properties that can be exploited for the treatment of cancers that have significantly… (more)

Subjects/Keywords: Biomedical engineering; Nanotechnology; Immunology; anti-CTLA-4; cancer; photothermal immunotherapy; Prussian blue nanoparticles

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Cano-Mejia, J. (2015). Biodegradable Prussian blue nanoparticles for photothermal immunotherapy of advanced cancers. (Thesis). University of Maryland. Retrieved from http://hdl.handle.net/1903/17364

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Cano-Mejia, Juliana. “Biodegradable Prussian blue nanoparticles for photothermal immunotherapy of advanced cancers.” 2015. Thesis, University of Maryland. Accessed January 17, 2021. http://hdl.handle.net/1903/17364.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Cano-Mejia, Juliana. “Biodegradable Prussian blue nanoparticles for photothermal immunotherapy of advanced cancers.” 2015. Web. 17 Jan 2021.

Vancouver:

Cano-Mejia J. Biodegradable Prussian blue nanoparticles for photothermal immunotherapy of advanced cancers. [Internet] [Thesis]. University of Maryland; 2015. [cited 2021 Jan 17]. Available from: http://hdl.handle.net/1903/17364.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Cano-Mejia J. Biodegradable Prussian blue nanoparticles for photothermal immunotherapy of advanced cancers. [Thesis]. University of Maryland; 2015. Available from: http://hdl.handle.net/1903/17364

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

14. Bouros, Spyridon. Μελέτη των πολυμορφισμών του γονιδίου CTLA-4 σε ασθενείς με μελάνωμα υψηλού κινδύνου για υποτροπή, που λαμβάνουν θεραπεία με ιντερφερόνη και συσχέτισή τους με την πρόγνωση.

Degree: 2014, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)

Purpose: Interferon is approved for adjuvant treatment of patients with stage IIb/III melanoma. The toxicity and uncertainty regarding survival benefits of interferon have qualified its… (more)

Subjects/Keywords: Μελάνωμα; Προγνωστικός παράγοντας; Μαθηματικό μοντέλο; Ιντερφερόνη; Melanoma; Interferon; CTLA-4; Prognostic factors; Mathematical model

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bouros, S. (2014). Μελέτη των πολυμορφισμών του γονιδίου CTLA-4 σε ασθενείς με μελάνωμα υψηλού κινδύνου για υποτροπή, που λαμβάνουν θεραπεία με ιντερφερόνη και συσχέτισή τους με την πρόγνωση. (Thesis). National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Retrieved from http://hdl.handle.net/10442/hedi/41686

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Bouros, Spyridon. “Μελέτη των πολυμορφισμών του γονιδίου CTLA-4 σε ασθενείς με μελάνωμα υψηλού κινδύνου για υποτροπή, που λαμβάνουν θεραπεία με ιντερφερόνη και συσχέτισή τους με την πρόγνωση.” 2014. Thesis, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Accessed January 17, 2021. http://hdl.handle.net/10442/hedi/41686.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Bouros, Spyridon. “Μελέτη των πολυμορφισμών του γονιδίου CTLA-4 σε ασθενείς με μελάνωμα υψηλού κινδύνου για υποτροπή, που λαμβάνουν θεραπεία με ιντερφερόνη και συσχέτισή τους με την πρόγνωση.” 2014. Web. 17 Jan 2021.

Vancouver:

Bouros S. Μελέτη των πολυμορφισμών του γονιδίου CTLA-4 σε ασθενείς με μελάνωμα υψηλού κινδύνου για υποτροπή, που λαμβάνουν θεραπεία με ιντερφερόνη και συσχέτισή τους με την πρόγνωση. [Internet] [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2014. [cited 2021 Jan 17]. Available from: http://hdl.handle.net/10442/hedi/41686.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Bouros S. Μελέτη των πολυμορφισμών του γονιδίου CTLA-4 σε ασθενείς με μελάνωμα υψηλού κινδύνου για υποτροπή, που λαμβάνουν θεραπεία με ιντερφερόνη και συσχέτισή τους με την πρόγνωση. [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2014. Available from: http://hdl.handle.net/10442/hedi/41686

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

15. 심, 지현. Altered Expression of Costimulatory Molecules in Behcet's Disease According to Clinical Activity.

Degree: 2010, Ajou University

 BACKGROUND: Behcet's Disease disease (BD) is a multisystemic inflammatory disorder. Several reports have suggested that autoimmunity, more precisely, failure to control autoreactive immune cells in… (more)

Subjects/Keywords: Behcet's Disease; CTLA-4; sCTLA-4; PD-L1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

심, . (2010). Altered Expression of Costimulatory Molecules in Behcet's Disease According to Clinical Activity. (Thesis). Ajou University. Retrieved from http://repository.ajou.ac.kr/handle/201003/1321 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000010486

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

심, 지현. “Altered Expression of Costimulatory Molecules in Behcet's Disease According to Clinical Activity.” 2010. Thesis, Ajou University. Accessed January 17, 2021. http://repository.ajou.ac.kr/handle/201003/1321 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000010486.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

심, 지현. “Altered Expression of Costimulatory Molecules in Behcet's Disease According to Clinical Activity.” 2010. Web. 17 Jan 2021.

Vancouver:

심 . Altered Expression of Costimulatory Molecules in Behcet's Disease According to Clinical Activity. [Internet] [Thesis]. Ajou University; 2010. [cited 2021 Jan 17]. Available from: http://repository.ajou.ac.kr/handle/201003/1321 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000010486.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

심 . Altered Expression of Costimulatory Molecules in Behcet's Disease According to Clinical Activity. [Thesis]. Ajou University; 2010. Available from: http://repository.ajou.ac.kr/handle/201003/1321 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000010486

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

16. Vinot, Pierre-Axel. Développement de pseudo-particules rétrovirales comme vaccin tolérogène et application dans l'allergie alimentaire : Retrovirus derived Virus-like particles as tolerogenic vaccines for food allergy treatment.

Degree: Docteur es, Immunologie, 2018, Sorbonne université

L’incidence croissante des désordres immunitaires a motivé le développement de nouvelles approches permettant l’induction d’une tolérance immunitaire spécifique et maintenue dans le temps. S’inscrivant dans… (more)

Subjects/Keywords: Immunologie; Immunothérapie; Tolérance; Pseudo-particules rétrovirales; Allergie; CTLA-4; Immunology; Immunotherapy; Virus-like particles; Allergy; 571.963

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Vinot, P. (2018). Développement de pseudo-particules rétrovirales comme vaccin tolérogène et application dans l'allergie alimentaire : Retrovirus derived Virus-like particles as tolerogenic vaccines for food allergy treatment. (Doctoral Dissertation). Sorbonne université. Retrieved from http://www.theses.fr/2018SORUS268

Chicago Manual of Style (16th Edition):

Vinot, Pierre-Axel. “Développement de pseudo-particules rétrovirales comme vaccin tolérogène et application dans l'allergie alimentaire : Retrovirus derived Virus-like particles as tolerogenic vaccines for food allergy treatment.” 2018. Doctoral Dissertation, Sorbonne université. Accessed January 17, 2021. http://www.theses.fr/2018SORUS268.

MLA Handbook (7th Edition):

Vinot, Pierre-Axel. “Développement de pseudo-particules rétrovirales comme vaccin tolérogène et application dans l'allergie alimentaire : Retrovirus derived Virus-like particles as tolerogenic vaccines for food allergy treatment.” 2018. Web. 17 Jan 2021.

Vancouver:

Vinot P. Développement de pseudo-particules rétrovirales comme vaccin tolérogène et application dans l'allergie alimentaire : Retrovirus derived Virus-like particles as tolerogenic vaccines for food allergy treatment. [Internet] [Doctoral dissertation]. Sorbonne université; 2018. [cited 2021 Jan 17]. Available from: http://www.theses.fr/2018SORUS268.

Council of Science Editors:

Vinot P. Développement de pseudo-particules rétrovirales comme vaccin tolérogène et application dans l'allergie alimentaire : Retrovirus derived Virus-like particles as tolerogenic vaccines for food allergy treatment. [Doctoral Dissertation]. Sorbonne université; 2018. Available from: http://www.theses.fr/2018SORUS268


Universitat de Girona

17. Bosch Vizcaya, Anna. Antígens menors d'histocompatibilitat en el trasplantament al·logènic de progenitors hematopoètics. Modulació de la resposta en funció del genotip CTLA-4.

Degree: Departament de Ciències Mèdiques, 2016, Universitat de Girona

 Els antígens menors d’histocompatibilitat (AgsmH) són pèptids precedents de proteïnes polimòrfiques endògenes que poden ser reconegudes en un context al·logènic pels limfòcits T del donant,… (more)

Subjects/Keywords: Antígens menors d'histocompatibilitat; Antígenos menores de histocompatibilidad; Minor histocompatibility antigens; Trasplantament al·logènic; Trasplante alogénico; Allogeneic transplantation; CTLA-4; 576; 61

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bosch Vizcaya, A. (2016). Antígens menors d'histocompatibilitat en el trasplantament al·logènic de progenitors hematopoètics. Modulació de la resposta en funció del genotip CTLA-4. (Thesis). Universitat de Girona. Retrieved from http://hdl.handle.net/10803/398011

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Bosch Vizcaya, Anna. “Antígens menors d'histocompatibilitat en el trasplantament al·logènic de progenitors hematopoètics. Modulació de la resposta en funció del genotip CTLA-4.” 2016. Thesis, Universitat de Girona. Accessed January 17, 2021. http://hdl.handle.net/10803/398011.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Bosch Vizcaya, Anna. “Antígens menors d'histocompatibilitat en el trasplantament al·logènic de progenitors hematopoètics. Modulació de la resposta en funció del genotip CTLA-4.” 2016. Web. 17 Jan 2021.

Vancouver:

Bosch Vizcaya A. Antígens menors d'histocompatibilitat en el trasplantament al·logènic de progenitors hematopoètics. Modulació de la resposta en funció del genotip CTLA-4. [Internet] [Thesis]. Universitat de Girona; 2016. [cited 2021 Jan 17]. Available from: http://hdl.handle.net/10803/398011.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Bosch Vizcaya A. Antígens menors d'histocompatibilitat en el trasplantament al·logènic de progenitors hematopoètics. Modulació de la resposta en funció del genotip CTLA-4. [Thesis]. Universitat de Girona; 2016. Available from: http://hdl.handle.net/10803/398011

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

18. Deshpande, Janhavee. Cell-mediated immunotherapy: its role in cancer treatment.

Degree: MS, Medical Sciences, 2017, Boston University

 Cancer is the second most common cause of death in the United States behind heart disease. While current treatments such as surgery, chemotherapy, and radiation… (more)

Subjects/Keywords: Immunology; CTLA-4; PD-1; Immunotherapy

…results of anti-CTLA-4 mAb on advanced 48 melanoma patients. 12 The CTLA-4, PD-1, and PD-L1… …FIGURES Figure 1 Title The blockade of PD-1 and CTLA-4 signaling in tumor Page 3… …Carcinoembryonic antigen CTL …..Cytotoxic T Lymphocytes CTLA-4… …CTLA-4) receptors and programmed death 1 receptor and its ligand (PD-1, PD-L1)… …T lymphocytes recognize CTLA-4 and PD-1 on cancer cells, which allows the cancer cells to… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Deshpande, J. (2017). Cell-mediated immunotherapy: its role in cancer treatment. (Masters Thesis). Boston University. Retrieved from http://hdl.handle.net/2144/23796

Chicago Manual of Style (16th Edition):

Deshpande, Janhavee. “Cell-mediated immunotherapy: its role in cancer treatment.” 2017. Masters Thesis, Boston University. Accessed January 17, 2021. http://hdl.handle.net/2144/23796.

MLA Handbook (7th Edition):

Deshpande, Janhavee. “Cell-mediated immunotherapy: its role in cancer treatment.” 2017. Web. 17 Jan 2021.

Vancouver:

Deshpande J. Cell-mediated immunotherapy: its role in cancer treatment. [Internet] [Masters thesis]. Boston University; 2017. [cited 2021 Jan 17]. Available from: http://hdl.handle.net/2144/23796.

Council of Science Editors:

Deshpande J. Cell-mediated immunotherapy: its role in cancer treatment. [Masters Thesis]. Boston University; 2017. Available from: http://hdl.handle.net/2144/23796


Arizona State University

19. Lussier, Danielle Marie. Increasing T Cell Immunity to Metastatic Osteosarcoma via Modulation of Inhibitory T Cell Receptors.

Degree: Molecular and Cellular Biology, 2015, Arizona State University

 Osteosarcoma is the most common bone cancer in children and adolescents. Patients with metastatic osteosarcoma are typically refractory to treatment. Numerous lines of evidence suggest… (more)

Subjects/Keywords: Immunology; Molecular biology; Cellular biology; CTLA-4; Inhibitory Receptors; Metastatic Osteosarcoma; PD-1; PD-L1; T cell exhaustion

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lussier, D. M. (2015). Increasing T Cell Immunity to Metastatic Osteosarcoma via Modulation of Inhibitory T Cell Receptors. (Doctoral Dissertation). Arizona State University. Retrieved from http://repository.asu.edu/items/29627

Chicago Manual of Style (16th Edition):

Lussier, Danielle Marie. “Increasing T Cell Immunity to Metastatic Osteosarcoma via Modulation of Inhibitory T Cell Receptors.” 2015. Doctoral Dissertation, Arizona State University. Accessed January 17, 2021. http://repository.asu.edu/items/29627.

MLA Handbook (7th Edition):

Lussier, Danielle Marie. “Increasing T Cell Immunity to Metastatic Osteosarcoma via Modulation of Inhibitory T Cell Receptors.” 2015. Web. 17 Jan 2021.

Vancouver:

Lussier DM. Increasing T Cell Immunity to Metastatic Osteosarcoma via Modulation of Inhibitory T Cell Receptors. [Internet] [Doctoral dissertation]. Arizona State University; 2015. [cited 2021 Jan 17]. Available from: http://repository.asu.edu/items/29627.

Council of Science Editors:

Lussier DM. Increasing T Cell Immunity to Metastatic Osteosarcoma via Modulation of Inhibitory T Cell Receptors. [Doctoral Dissertation]. Arizona State University; 2015. Available from: http://repository.asu.edu/items/29627

20. Marabelle, Aurélien. Targeting Tumor Specific Regulatory T-cells for Cancer Therapy : Traitement du Cancer par Ciblage des Lymphocytes T-régulateurs Spécifiques des Antigènes Tumoraux.

Degree: Docteur es, Sciences de la Vie, 2013, Lyon, École normale supérieure

L'activation de TLR9 par injection directe de nucléotides CpG non méthylés dans une tumeur peut induire une réponse immunitaire thérapeutique, mais les lymphocytes T régulateurs… (more)

Subjects/Keywords: Cancer; Immunothérapies; Lymphocytes T-régulateurs; Anticorps immunomodulateurs; CTLA-4; OX40; CpG; Toll-Like Receptor 9; Cancer; Immunotherapies; Regulatory T-cells; Checkpoint blockade antibodies; CTLA-4; OX40; CpG; Toll-Like Receptor 9

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Marabelle, A. (2013). Targeting Tumor Specific Regulatory T-cells for Cancer Therapy : Traitement du Cancer par Ciblage des Lymphocytes T-régulateurs Spécifiques des Antigènes Tumoraux. (Doctoral Dissertation). Lyon, École normale supérieure. Retrieved from http://www.theses.fr/2013ENSL0832

Chicago Manual of Style (16th Edition):

Marabelle, Aurélien. “Targeting Tumor Specific Regulatory T-cells for Cancer Therapy : Traitement du Cancer par Ciblage des Lymphocytes T-régulateurs Spécifiques des Antigènes Tumoraux.” 2013. Doctoral Dissertation, Lyon, École normale supérieure. Accessed January 17, 2021. http://www.theses.fr/2013ENSL0832.

MLA Handbook (7th Edition):

Marabelle, Aurélien. “Targeting Tumor Specific Regulatory T-cells for Cancer Therapy : Traitement du Cancer par Ciblage des Lymphocytes T-régulateurs Spécifiques des Antigènes Tumoraux.” 2013. Web. 17 Jan 2021.

Vancouver:

Marabelle A. Targeting Tumor Specific Regulatory T-cells for Cancer Therapy : Traitement du Cancer par Ciblage des Lymphocytes T-régulateurs Spécifiques des Antigènes Tumoraux. [Internet] [Doctoral dissertation]. Lyon, École normale supérieure; 2013. [cited 2021 Jan 17]. Available from: http://www.theses.fr/2013ENSL0832.

Council of Science Editors:

Marabelle A. Targeting Tumor Specific Regulatory T-cells for Cancer Therapy : Traitement du Cancer par Ciblage des Lymphocytes T-régulateurs Spécifiques des Antigènes Tumoraux. [Doctoral Dissertation]. Lyon, École normale supérieure; 2013. Available from: http://www.theses.fr/2013ENSL0832

21. Dupaty, Léa. Evaluation in vivo de protéines immunorégulatrices dérivées de CTLA-4 et de PD-L1 pour leur capacité à inhiber les réponses immunitaires dans le contexte de la thérapie génique musculaire par AAV : In-vivo evaluation of immunoregulatory proteins derived from CTLA-4 and PD-L1 for their capacity to inhibit immuno responses in a context of AAV muscle gene therapy.

Degree: Docteur es, Sciences de la vie et de la sante, 2018, Normandie

La thérapie génique consiste à introduire du matériel génétique dans des cellules dans l’objectif de traiter une pathologie. Le plus souvent, la thérapie génique s’effectue… (more)

Subjects/Keywords: Thérapie génique; Point de contrôle immunologique; Tolérance immunitaire; CTLA-4; PD-L1; Vecteur adéno-associé; Vectorisation; Gene Therapy; Immune checkpoint; Immune tolerance; CTLA-4; PD-L1; Adeno-associated vector; Vectorization; 615.8; 616.079

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dupaty, L. (2018). Evaluation in vivo de protéines immunorégulatrices dérivées de CTLA-4 et de PD-L1 pour leur capacité à inhiber les réponses immunitaires dans le contexte de la thérapie génique musculaire par AAV : In-vivo evaluation of immunoregulatory proteins derived from CTLA-4 and PD-L1 for their capacity to inhibit immuno responses in a context of AAV muscle gene therapy. (Doctoral Dissertation). Normandie. Retrieved from http://www.theses.fr/2018NORMR133

Chicago Manual of Style (16th Edition):

Dupaty, Léa. “Evaluation in vivo de protéines immunorégulatrices dérivées de CTLA-4 et de PD-L1 pour leur capacité à inhiber les réponses immunitaires dans le contexte de la thérapie génique musculaire par AAV : In-vivo evaluation of immunoregulatory proteins derived from CTLA-4 and PD-L1 for their capacity to inhibit immuno responses in a context of AAV muscle gene therapy.” 2018. Doctoral Dissertation, Normandie. Accessed January 17, 2021. http://www.theses.fr/2018NORMR133.

MLA Handbook (7th Edition):

Dupaty, Léa. “Evaluation in vivo de protéines immunorégulatrices dérivées de CTLA-4 et de PD-L1 pour leur capacité à inhiber les réponses immunitaires dans le contexte de la thérapie génique musculaire par AAV : In-vivo evaluation of immunoregulatory proteins derived from CTLA-4 and PD-L1 for their capacity to inhibit immuno responses in a context of AAV muscle gene therapy.” 2018. Web. 17 Jan 2021.

Vancouver:

Dupaty L. Evaluation in vivo de protéines immunorégulatrices dérivées de CTLA-4 et de PD-L1 pour leur capacité à inhiber les réponses immunitaires dans le contexte de la thérapie génique musculaire par AAV : In-vivo evaluation of immunoregulatory proteins derived from CTLA-4 and PD-L1 for their capacity to inhibit immuno responses in a context of AAV muscle gene therapy. [Internet] [Doctoral dissertation]. Normandie; 2018. [cited 2021 Jan 17]. Available from: http://www.theses.fr/2018NORMR133.

Council of Science Editors:

Dupaty L. Evaluation in vivo de protéines immunorégulatrices dérivées de CTLA-4 et de PD-L1 pour leur capacité à inhiber les réponses immunitaires dans le contexte de la thérapie génique musculaire par AAV : In-vivo evaluation of immunoregulatory proteins derived from CTLA-4 and PD-L1 for their capacity to inhibit immuno responses in a context of AAV muscle gene therapy. [Doctoral Dissertation]. Normandie; 2018. Available from: http://www.theses.fr/2018NORMR133


Texas Medical Center

22. Roh, Whijae. INTEGRATIVE CANCER IMMUNOGENOMIC ANALYSIS OF SERIAL MELANOMA BIOPSIES REVEALS CORRELATES OF RESPONSE AND RESISTANCE TO SEQUENTIAL CTLA-4 AND PD-1 BLOCKADE TREATMENT.

Degree: PhD, 2017, Texas Medical Center

  Melanoma is the most malignant form of skin cancer. The five-year survival rate for metastatic melanoma is 19.9%. Although targeted therapy of BRAF and… (more)

Subjects/Keywords: cancer immunology; immunotherapy; immune checkpoint blockade; CTLA-4; PD-1; genomics; melanoma; response; resistance; biomarker; Bioinformatics; Computational Biology; Genomics; Medical Immunology; Medicine and Health Sciences; Skin and Connective Tissue Diseases

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Roh, W. (2017). INTEGRATIVE CANCER IMMUNOGENOMIC ANALYSIS OF SERIAL MELANOMA BIOPSIES REVEALS CORRELATES OF RESPONSE AND RESISTANCE TO SEQUENTIAL CTLA-4 AND PD-1 BLOCKADE TREATMENT. (Doctoral Dissertation). Texas Medical Center. Retrieved from https://digitalcommons.library.tmc.edu/utgsbs_dissertations/813

Chicago Manual of Style (16th Edition):

Roh, Whijae. “INTEGRATIVE CANCER IMMUNOGENOMIC ANALYSIS OF SERIAL MELANOMA BIOPSIES REVEALS CORRELATES OF RESPONSE AND RESISTANCE TO SEQUENTIAL CTLA-4 AND PD-1 BLOCKADE TREATMENT.” 2017. Doctoral Dissertation, Texas Medical Center. Accessed January 17, 2021. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/813.

MLA Handbook (7th Edition):

Roh, Whijae. “INTEGRATIVE CANCER IMMUNOGENOMIC ANALYSIS OF SERIAL MELANOMA BIOPSIES REVEALS CORRELATES OF RESPONSE AND RESISTANCE TO SEQUENTIAL CTLA-4 AND PD-1 BLOCKADE TREATMENT.” 2017. Web. 17 Jan 2021.

Vancouver:

Roh W. INTEGRATIVE CANCER IMMUNOGENOMIC ANALYSIS OF SERIAL MELANOMA BIOPSIES REVEALS CORRELATES OF RESPONSE AND RESISTANCE TO SEQUENTIAL CTLA-4 AND PD-1 BLOCKADE TREATMENT. [Internet] [Doctoral dissertation]. Texas Medical Center; 2017. [cited 2021 Jan 17]. Available from: https://digitalcommons.library.tmc.edu/utgsbs_dissertations/813.

Council of Science Editors:

Roh W. INTEGRATIVE CANCER IMMUNOGENOMIC ANALYSIS OF SERIAL MELANOMA BIOPSIES REVEALS CORRELATES OF RESPONSE AND RESISTANCE TO SEQUENTIAL CTLA-4 AND PD-1 BLOCKADE TREATMENT. [Doctoral Dissertation]. Texas Medical Center; 2017. Available from: https://digitalcommons.library.tmc.edu/utgsbs_dissertations/813


University of Debrecen

23. Ben Simon, Avner Israel. Recent developments in immunotherapy of malignant melanoma .

Degree: DE – Általános Orvostudományi Kar, University of Debrecen

Recent advances in research and treatments for malignant melanoma. genetically targeted therapy, immune modulating therapy including Checkpoint Inhibitors, Signal-Transduction Inhibitors and their effect on the course of the disease. Advisors/Committee Members: Megyeri, Attila (advisor), Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet (advisor).

Subjects/Keywords: immunotherapy; melanoma; Checkpoint Inhibitors; Anti–PD; Anti–CTLA-4; BRAF Inhibitors; PD-L1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ben Simon, A. I. (n.d.). Recent developments in immunotherapy of malignant melanoma . (Thesis). University of Debrecen. Retrieved from http://hdl.handle.net/2437/257243

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Ben Simon, Avner Israel. “Recent developments in immunotherapy of malignant melanoma .” Thesis, University of Debrecen. Accessed January 17, 2021. http://hdl.handle.net/2437/257243.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Ben Simon, Avner Israel. “Recent developments in immunotherapy of malignant melanoma .” Web. 17 Jan 2021.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Ben Simon AI. Recent developments in immunotherapy of malignant melanoma . [Internet] [Thesis]. University of Debrecen; [cited 2021 Jan 17]. Available from: http://hdl.handle.net/2437/257243.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Ben Simon AI. Recent developments in immunotherapy of malignant melanoma . [Thesis]. University of Debrecen; Available from: http://hdl.handle.net/2437/257243

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


University of Debrecen

24. Najar, Diar Karim. Recent results with immune checkpoint inhibitors in advanced-stage non-small cell lung cancer .

Degree: DE – Általános Orvostudományi Kar, University of Debrecen

 I have done my thesis about Recent results with immune checkpoint inhibitors in advanced stage non small cell lung cancer. In my thesis I discuss… (more)

Subjects/Keywords: Thesis; Immun-oncotherapy; PD-1L Inhibitors; CTLA-4 Blockers; Pharmacology; PD-1 Inhibitors

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Najar, D. K. (n.d.). Recent results with immune checkpoint inhibitors in advanced-stage non-small cell lung cancer . (Thesis). University of Debrecen. Retrieved from http://hdl.handle.net/2437/280310

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Najar, Diar Karim. “Recent results with immune checkpoint inhibitors in advanced-stage non-small cell lung cancer .” Thesis, University of Debrecen. Accessed January 17, 2021. http://hdl.handle.net/2437/280310.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Najar, Diar Karim. “Recent results with immune checkpoint inhibitors in advanced-stage non-small cell lung cancer .” Web. 17 Jan 2021.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Najar DK. Recent results with immune checkpoint inhibitors in advanced-stage non-small cell lung cancer . [Internet] [Thesis]. University of Debrecen; [cited 2021 Jan 17]. Available from: http://hdl.handle.net/2437/280310.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Najar DK. Recent results with immune checkpoint inhibitors in advanced-stage non-small cell lung cancer . [Thesis]. University of Debrecen; Available from: http://hdl.handle.net/2437/280310

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

25. Πεκτασίδη, Ειρήνη. Μελέτη των πολυμορφισμών του γονιδίου CTLA-4 σε ασθενείς με κακόηθες μελάνωμα.

Degree: 2009, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)

Purpose: Interferon is approved for adjuvant treatment of patients with stage llb/lll melanoma. The toxicity and uncertainty regarding survival benefits of interferon have qualified its… (more)

Subjects/Keywords: Μελάνωμα; Πολυμορφισμός; Επικουρική θεραπεία; Ιντερφερόνη; Melanoma; Polymorphisms; CTLA-4; Adjuvant therapy; Interferon

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Πεκτασίδη, . . (2009). Μελέτη των πολυμορφισμών του γονιδίου CTLA-4 σε ασθενείς με κακόηθες μελάνωμα. (Thesis). National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Retrieved from http://hdl.handle.net/10442/hedi/29732

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Πεκτασίδη, Ειρήνη. “Μελέτη των πολυμορφισμών του γονιδίου CTLA-4 σε ασθενείς με κακόηθες μελάνωμα.” 2009. Thesis, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Accessed January 17, 2021. http://hdl.handle.net/10442/hedi/29732.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Πεκτασίδη, Ειρήνη. “Μελέτη των πολυμορφισμών του γονιδίου CTLA-4 σε ασθενείς με κακόηθες μελάνωμα.” 2009. Web. 17 Jan 2021.

Vancouver:

Πεκτασίδη . Μελέτη των πολυμορφισμών του γονιδίου CTLA-4 σε ασθενείς με κακόηθες μελάνωμα. [Internet] [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2009. [cited 2021 Jan 17]. Available from: http://hdl.handle.net/10442/hedi/29732.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Πεκτασίδη . Μελέτη των πολυμορφισμών του γονιδίου CTLA-4 σε ασθενείς με κακόηθες μελάνωμα. [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2009. Available from: http://hdl.handle.net/10442/hedi/29732

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

26. Anderson, Kathleen. CD25+ CTLA-4+ T Cell-Dependent Induction of Anergic CD25- T Cells Limits the Immune Response to H. pylori Infection Resulting in Mild Gastritis and Persistent Colonization.

Degree: PhD, Pathology, 2006, Case Western Reserve University School of Graduate Studies

 Helicobacter pylori (H. pylori) is a gastric pathogen infecting more than half the world’s population. H. pylori infection induces gastric inflammation but the host fails… (more)

Subjects/Keywords: Health Sciences, Immunology; H. pylori; anergy; regulatory T cells; CTLA-4

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Anderson, K. (2006). CD25+ CTLA-4+ T Cell-Dependent Induction of Anergic CD25- T Cells Limits the Immune Response to H. pylori Infection Resulting in Mild Gastritis and Persistent Colonization. (Doctoral Dissertation). Case Western Reserve University School of Graduate Studies. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=case1144332338

Chicago Manual of Style (16th Edition):

Anderson, Kathleen. “CD25+ CTLA-4+ T Cell-Dependent Induction of Anergic CD25- T Cells Limits the Immune Response to H. pylori Infection Resulting in Mild Gastritis and Persistent Colonization.” 2006. Doctoral Dissertation, Case Western Reserve University School of Graduate Studies. Accessed January 17, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=case1144332338.

MLA Handbook (7th Edition):

Anderson, Kathleen. “CD25+ CTLA-4+ T Cell-Dependent Induction of Anergic CD25- T Cells Limits the Immune Response to H. pylori Infection Resulting in Mild Gastritis and Persistent Colonization.” 2006. Web. 17 Jan 2021.

Vancouver:

Anderson K. CD25+ CTLA-4+ T Cell-Dependent Induction of Anergic CD25- T Cells Limits the Immune Response to H. pylori Infection Resulting in Mild Gastritis and Persistent Colonization. [Internet] [Doctoral dissertation]. Case Western Reserve University School of Graduate Studies; 2006. [cited 2021 Jan 17]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=case1144332338.

Council of Science Editors:

Anderson K. CD25+ CTLA-4+ T Cell-Dependent Induction of Anergic CD25- T Cells Limits the Immune Response to H. pylori Infection Resulting in Mild Gastritis and Persistent Colonization. [Doctoral Dissertation]. Case Western Reserve University School of Graduate Studies; 2006. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=case1144332338

27. Lévy, Eva. Identification de causes génétiques du syndrome d’Evans pédiatrique : Identifying genetic causes of pediatric Evans syndrome.

Degree: Docteur es, Immunologie, 2016, Sorbonne Paris Cité

 Le syndrome d'Evans est défini par l'existence concomitante ou séquentielle de cytopénies auto-immunes, le plus souvent, anémie hémolytique et thrombopénie immunologique. Chez l'enfant, il peut… (more)

Subjects/Keywords: Syndrome d'Evans; Anémie hémolytique auto-immune; Purpura thrombopénique immunologique; Auto-immunité; Maladie génétique; Séquençage de l'exome; LRBA; CTLA-4; STAT3 gain de fonction; Lymphocytes T régulateurs; Pédiatrie; Déficit immunitaire; Evans syndrome; Autoimmune hemolytic anemia; Immune thrombocytopenia; Autoimmunity; Genetic disease; Exome sequencing; LRBA; CTLA-4; STAT3 gain-of-function; Regulatory T lymphocytes; Pediatrics; Immune deficiency; 571.96

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lévy, E. (2016). Identification de causes génétiques du syndrome d’Evans pédiatrique : Identifying genetic causes of pediatric Evans syndrome. (Doctoral Dissertation). Sorbonne Paris Cité. Retrieved from http://www.theses.fr/2016USPCB017

Chicago Manual of Style (16th Edition):

Lévy, Eva. “Identification de causes génétiques du syndrome d’Evans pédiatrique : Identifying genetic causes of pediatric Evans syndrome.” 2016. Doctoral Dissertation, Sorbonne Paris Cité. Accessed January 17, 2021. http://www.theses.fr/2016USPCB017.

MLA Handbook (7th Edition):

Lévy, Eva. “Identification de causes génétiques du syndrome d’Evans pédiatrique : Identifying genetic causes of pediatric Evans syndrome.” 2016. Web. 17 Jan 2021.

Vancouver:

Lévy E. Identification de causes génétiques du syndrome d’Evans pédiatrique : Identifying genetic causes of pediatric Evans syndrome. [Internet] [Doctoral dissertation]. Sorbonne Paris Cité; 2016. [cited 2021 Jan 17]. Available from: http://www.theses.fr/2016USPCB017.

Council of Science Editors:

Lévy E. Identification de causes génétiques du syndrome d’Evans pédiatrique : Identifying genetic causes of pediatric Evans syndrome. [Doctoral Dissertation]. Sorbonne Paris Cité; 2016. Available from: http://www.theses.fr/2016USPCB017


Texas Medical Center

28. Jaiswal, Ashvin. TUMOR IMMUNOTHERAPY: MECHANISMS OF ACQUIRED RESISTANCE AND CHARACTERIZATION OF IMMUNE RELATED TOXICITIES.

Degree: PhD, 2018, Texas Medical Center

  Tumor immunotherapy has shown very promising clinical benefit across an array of cancers; however, two major challenges remain unresolved in the field. First, many… (more)

Subjects/Keywords: Immunotherapy Resistance; Immunooncology; CTLA-4; PD-1; PD-L1; 4-1BB; Immune Related Adverse Effects (IRAEs); Immunometabolism; Checkpoint Blockade Immunotherapy; Hepatotoxicity; Genetic Processes; Immunity; Immunology and Infectious Disease; Immunopathology; Immunoprophylaxis and Therapy; Medical Biochemistry; Medical Biotechnology; Medical Genetics; Medical Immunology; Medicine and Health Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jaiswal, A. (2018). TUMOR IMMUNOTHERAPY: MECHANISMS OF ACQUIRED RESISTANCE AND CHARACTERIZATION OF IMMUNE RELATED TOXICITIES. (Doctoral Dissertation). Texas Medical Center. Retrieved from https://digitalcommons.library.tmc.edu/utgsbs_dissertations/832

Chicago Manual of Style (16th Edition):

Jaiswal, Ashvin. “TUMOR IMMUNOTHERAPY: MECHANISMS OF ACQUIRED RESISTANCE AND CHARACTERIZATION OF IMMUNE RELATED TOXICITIES.” 2018. Doctoral Dissertation, Texas Medical Center. Accessed January 17, 2021. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/832.

MLA Handbook (7th Edition):

Jaiswal, Ashvin. “TUMOR IMMUNOTHERAPY: MECHANISMS OF ACQUIRED RESISTANCE AND CHARACTERIZATION OF IMMUNE RELATED TOXICITIES.” 2018. Web. 17 Jan 2021.

Vancouver:

Jaiswal A. TUMOR IMMUNOTHERAPY: MECHANISMS OF ACQUIRED RESISTANCE AND CHARACTERIZATION OF IMMUNE RELATED TOXICITIES. [Internet] [Doctoral dissertation]. Texas Medical Center; 2018. [cited 2021 Jan 17]. Available from: https://digitalcommons.library.tmc.edu/utgsbs_dissertations/832.

Council of Science Editors:

Jaiswal A. TUMOR IMMUNOTHERAPY: MECHANISMS OF ACQUIRED RESISTANCE AND CHARACTERIZATION OF IMMUNE RELATED TOXICITIES. [Doctoral Dissertation]. Texas Medical Center; 2018. Available from: https://digitalcommons.library.tmc.edu/utgsbs_dissertations/832


Université de Montréal

29. Bastien, Jean-Philippe. Traitement de la maladie du greffon contre l’hôte chronique par la photophérèse extra corporelle au TH9402 : m écanisme de régulation de la maladie du greffon contre l’hôte chronique par les cellules T régulatrices.

Degree: 2016, Université de Montréal

Subjects/Keywords: GVHD chronique; TH9402; Cellule T régulatrice; CTLA-4; IDO; GCN2; Cellules dendritiques; Chronic GVHD; TH9402; Regulatory T cells; CTLA-4; IDO; GCN2; Dendritic cells; Health Sciences - Immunology / Sciences de la santé - Immunologie (UMI : 0982)

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bastien, J. (2016). Traitement de la maladie du greffon contre l’hôte chronique par la photophérèse extra corporelle au TH9402 : m écanisme de régulation de la maladie du greffon contre l’hôte chronique par les cellules T régulatrices. (Thesis). Université de Montréal. Retrieved from http://hdl.handle.net/1866/15983

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Bastien, Jean-Philippe. “Traitement de la maladie du greffon contre l’hôte chronique par la photophérèse extra corporelle au TH9402 : m écanisme de régulation de la maladie du greffon contre l’hôte chronique par les cellules T régulatrices.” 2016. Thesis, Université de Montréal. Accessed January 17, 2021. http://hdl.handle.net/1866/15983.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Bastien, Jean-Philippe. “Traitement de la maladie du greffon contre l’hôte chronique par la photophérèse extra corporelle au TH9402 : m écanisme de régulation de la maladie du greffon contre l’hôte chronique par les cellules T régulatrices.” 2016. Web. 17 Jan 2021.

Vancouver:

Bastien J. Traitement de la maladie du greffon contre l’hôte chronique par la photophérèse extra corporelle au TH9402 : m écanisme de régulation de la maladie du greffon contre l’hôte chronique par les cellules T régulatrices. [Internet] [Thesis]. Université de Montréal; 2016. [cited 2021 Jan 17]. Available from: http://hdl.handle.net/1866/15983.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Bastien J. Traitement de la maladie du greffon contre l’hôte chronique par la photophérèse extra corporelle au TH9402 : m écanisme de régulation de la maladie du greffon contre l’hôte chronique par les cellules T régulatrices. [Thesis]. Université de Montréal; 2016. Available from: http://hdl.handle.net/1866/15983

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Queensland

30. Harjunpaa, Heidi Margareta. Tumor immunity and autoimmunity following cancer immunotherapy.

Degree: School of Medicine, 2019, University of Queensland

Subjects/Keywords: Cancer; Immunotherapy; IrAEs; Immune checkpoint receptor; CTLA-4; PD-1; CD96; TIGIT; Multiple myeloma; 1107 Immunology; 1112 Oncology and Carcinogenesis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Harjunpaa, H. M. (2019). Tumor immunity and autoimmunity following cancer immunotherapy. (Thesis). University of Queensland. Retrieved from http://espace.library.uq.edu.au/view/UQ:6

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Harjunpaa, Heidi Margareta. “Tumor immunity and autoimmunity following cancer immunotherapy.” 2019. Thesis, University of Queensland. Accessed January 17, 2021. http://espace.library.uq.edu.au/view/UQ:6.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Harjunpaa, Heidi Margareta. “Tumor immunity and autoimmunity following cancer immunotherapy.” 2019. Web. 17 Jan 2021.

Vancouver:

Harjunpaa HM. Tumor immunity and autoimmunity following cancer immunotherapy. [Internet] [Thesis]. University of Queensland; 2019. [cited 2021 Jan 17]. Available from: http://espace.library.uq.edu.au/view/UQ:6.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Harjunpaa HM. Tumor immunity and autoimmunity following cancer immunotherapy. [Thesis]. University of Queensland; 2019. Available from: http://espace.library.uq.edu.au/view/UQ:6

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

[1] [2]

.